Global Neurological Biomarkers Market Size study, by Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism Spectrum Disorder, Others), By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By End-use (Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations and Others) and Regional Forecasts 2021-2027
Global Neurological Biomarkers Market is valued approximately USD 6.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 12.9% over the forecast period 2021-2027. Alzheimer's disease and Parkinson's disease are neurodegenerative illnesses that cause progressive loss of cognitive function, dementia, and movement difficulties. The rise in the incidence of neurological diseases such as migraines, dementia, Alzheimer's disease, brain tumours, and epilepsy can be contributed to the market's expansion. Furthermore, technological advances and the growing demand for early detection of neurological diseases are driving the market growth. In 2019, according to the WHO (World Health Organization), epilepsy accounted for about 13 million disability-adjusted lifespan and more than 0.5 percent of the global burden of illness. The market is projected to expand as the number of instances of Alzheimer's disease among the elderly population rises. However, the market is expected to be hampered by the adoption of strict government rules for the authorization of commercial use of biomarkers, as well as increasing ethical problems surrounding early detection of Alzheimer's and Parkinson's diseases. Whereas, the growth in demand for customized medicine is expected to provide opportunities for neurological biomarker market growth in forecasting years.
The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Neurological Biomarkers market. North America held the largest market share in 2020 and is anticipated to expand at a significant CAGR throughout the forecast period. The region's dominance is due to a considerable rise in illness burden, adoption of biomarkers for diagnostic, therapeutic development, and prognostic reasons, and increased research funding. Furthermore, in forecasting years, Asia Pacific is anticipated to expand at the fastest CAGR. The Asia Pacific region is projected to be driven by an increase in the number of clinical trials undertaken in emerging nations such as India and China, increased illness burden, and growing demand for targeted medicines in the central nervous system.
Major market player included in this report are:
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Banyan Biomarkers, Inc.
Myriad Genetics, Inc.
DiaGenic ASA
Quanterix
Myriad RBM
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others
By Type:
Genomic
Proteomic
Metabolomic
Imaging
Others
By End-use:
Hospital & Hospital Laboratories
Independent Clinical Diagnostic Centers
Research Organizations and Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Neurological Biomarkers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Neurological Biomarkers market. North America held the largest market share in 2020 and is anticipated to expand at a significant CAGR throughout the forecast period. The region's dominance is due to a considerable rise in illness burden, adoption of biomarkers for diagnostic, therapeutic development, and prognostic reasons, and increased research funding. Furthermore, in forecasting years, Asia Pacific is anticipated to expand at the fastest CAGR. The Asia Pacific region is projected to be driven by an increase in the number of clinical trials undertaken in emerging nations such as India and China, increased illness burden, and growing demand for targeted medicines in the central nervous system.
Major market player included in this report are:
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Banyan Biomarkers, Inc.
Myriad Genetics, Inc.
DiaGenic ASA
Quanterix
Myriad RBM
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others
By Type:
Genomic
Proteomic
Metabolomic
Imaging
Others
By End-use:
Hospital & Hospital Laboratories
Independent Clinical Diagnostic Centers
Research Organizations and Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Neurological Biomarkers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Neurological Biomarkers Market, by Region, 2019-2027 (USD Billion)
1.2.2. Neurological Biomarkers Market, by Application, 2019-2027 (USD Billion)
1.2.3. Neurological Biomarkers Market, by Type, 2019-2027 (USD Billion)
1.2.4. Neurological Biomarkers Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROLOGICAL BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET DYNAMICS
3.1. Neurological Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of neurological diseases
3.1.1.2. Increasing investment for R&D activities
3.1.2. Market Challenges
3.1.2.1. Lack of consumer awareness
3.1.3. Market Opportunities
3.1.3.1. Development in technology in biomarkers
CHAPTER 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION
5.1. Market Snapshot
5.2. Global Neurological Biomarkers Market by Application, Performance - Potential Analysis
5.3. Global Neurological Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
5.4. Neurological Biomarkers Market, Sub Segment Analysis
5.4.1. Alzheimer’s Disease
5.4.2. Parkinson’s Disease
5.4.3. Multiple Sclerosis
5.4.4. Autism Spectrum Disorder
5.4.5. Others
CHAPTER 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY TYPE,
6.1. Market Snapshot
6.2. Global Neurological Biomarkers Market by Type, Performance-Potential Analysis
6.3. Global Neurological Biomarkers Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)
6.4. Neurological Biomarkers Market, Sub Segment Analysis
6.4.1. Genomic
6.4.2. Proteomic
6.4.3. Metabolomic
6.4.4. Imaging
6.4.5. Others
CHAPTER 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE,
7.1. Market Snapshot
7.2. Global Neurological Biomarkers Market by End-use, Performance-Potential Analysis
7.3. Global Neurological Biomarkers Market Estimates & Forecasts by End-use, 2018-2027 (USD Billion)
7.4. Neurological Biomarkers Market, Sub Segment Analysis
7.4.1. Hospital & Hospital Laboratories
7.4.2. Independent Clinical Diagnostic Centers
7.4.3. Research Organizations and Others
CHAPTER 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, REGIONAL ANALYSIS
8.1. Neurological Biomarkers Market, Regional Market Snapshot
8.2. North America Neurological Biomarkers Market
8.2.1. U.S. Neurological Biomarkers Market
8.2.1.1. Application breakdown estimates & forecasts, 2018-2027
8.2.1.2. Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimated & forecasts, 2018-2027
8.2.2. Canada Neurological Biomarkers Market
8.3. Europe Neurological Biomarkers Market Snapshot
8.3.1. U.K. Neurological Biomarkers Market
8.3.2. Germany Neurological Biomarkers Market
8.3.3. France Neurological Biomarkers Market
8.3.4. Spain Neurological Biomarkers Market
8.3.5. Italy Neurological Biomarkers Market
8.3.6. Rest of Europe Neurological Biomarkers Market
8.4. Asia-Pacific Neurological Biomarkers Market Snapshot
8.4.1. China Neurological Biomarkers Market
8.4.2. India Neurological Biomarkers Market
8.4.3. Japan Neurological Biomarkers Market
8.4.4. Australia Neurological Biomarkers Market
8.4.5. South Korea Neurological Biomarkers Market
8.4.6. Rest of Asia Pacific Neurological Biomarkers Market
8.5. Latin America Neurological Biomarkers Market Snapshot
8.5.1. Brazil Neurological Biomarkers Market
8.5.2. Mexico Neurological Biomarkers Market
8.6. Rest of The World Neurological Biomarkers Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Application Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific, Inc.
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Merck & Co., Inc.
9.2.5. Johnson & Johnson Services, Inc.
9.2.6. Banyan Biomarkers, Inc.
9.2.7. Myriad Genetics, Inc.
9.2.8. DiaGenic ASA
9.2.9. Quanterix
9.2.10. Myriad RBM
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Neurological Biomarkers Market, by Region, 2019-2027 (USD Billion)
1.2.2. Neurological Biomarkers Market, by Application, 2019-2027 (USD Billion)
1.2.3. Neurological Biomarkers Market, by Type, 2019-2027 (USD Billion)
1.2.4. Neurological Biomarkers Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROLOGICAL BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROLOGICAL BIOMARKERS MARKET DYNAMICS
3.1. Neurological Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of neurological diseases
3.1.1.2. Increasing investment for R&D activities
3.1.2. Market Challenges
3.1.2.1. Lack of consumer awareness
3.1.3. Market Opportunities
3.1.3.1. Development in technology in biomarkers
CHAPTER 4. GLOBAL NEUROLOGICAL BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION
5.1. Market Snapshot
5.2. Global Neurological Biomarkers Market by Application, Performance - Potential Analysis
5.3. Global Neurological Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
5.4. Neurological Biomarkers Market, Sub Segment Analysis
5.4.1. Alzheimer’s Disease
5.4.2. Parkinson’s Disease
5.4.3. Multiple Sclerosis
5.4.4. Autism Spectrum Disorder
5.4.5. Others
CHAPTER 6. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY TYPE,
6.1. Market Snapshot
6.2. Global Neurological Biomarkers Market by Type, Performance-Potential Analysis
6.3. Global Neurological Biomarkers Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)
6.4. Neurological Biomarkers Market, Sub Segment Analysis
6.4.1. Genomic
6.4.2. Proteomic
6.4.3. Metabolomic
6.4.4. Imaging
6.4.5. Others
CHAPTER 7. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE,
7.1. Market Snapshot
7.2. Global Neurological Biomarkers Market by End-use, Performance-Potential Analysis
7.3. Global Neurological Biomarkers Market Estimates & Forecasts by End-use, 2018-2027 (USD Billion)
7.4. Neurological Biomarkers Market, Sub Segment Analysis
7.4.1. Hospital & Hospital Laboratories
7.4.2. Independent Clinical Diagnostic Centers
7.4.3. Research Organizations and Others
CHAPTER 8. GLOBAL NEUROLOGICAL BIOMARKERS MARKET, REGIONAL ANALYSIS
8.1. Neurological Biomarkers Market, Regional Market Snapshot
8.2. North America Neurological Biomarkers Market
8.2.1. U.S. Neurological Biomarkers Market
8.2.1.1. Application breakdown estimates & forecasts, 2018-2027
8.2.1.2. Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimated & forecasts, 2018-2027
8.2.2. Canada Neurological Biomarkers Market
8.3. Europe Neurological Biomarkers Market Snapshot
8.3.1. U.K. Neurological Biomarkers Market
8.3.2. Germany Neurological Biomarkers Market
8.3.3. France Neurological Biomarkers Market
8.3.4. Spain Neurological Biomarkers Market
8.3.5. Italy Neurological Biomarkers Market
8.3.6. Rest of Europe Neurological Biomarkers Market
8.4. Asia-Pacific Neurological Biomarkers Market Snapshot
8.4.1. China Neurological Biomarkers Market
8.4.2. India Neurological Biomarkers Market
8.4.3. Japan Neurological Biomarkers Market
8.4.4. Australia Neurological Biomarkers Market
8.4.5. South Korea Neurological Biomarkers Market
8.4.6. Rest of Asia Pacific Neurological Biomarkers Market
8.5. Latin America Neurological Biomarkers Market Snapshot
8.5.1. Brazil Neurological Biomarkers Market
8.5.2. Mexico Neurological Biomarkers Market
8.6. Rest of The World Neurological Biomarkers Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Application Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific, Inc.
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Merck & Co., Inc.
9.2.5. Johnson & Johnson Services, Inc.
9.2.6. Banyan Biomarkers, Inc.
9.2.7. Myriad Genetics, Inc.
9.2.8. DiaGenic ASA
9.2.9. Quanterix
9.2.10. Myriad RBM
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Neurological Biomarkers Market , report scope
TABLE 2. Global Neurological Biomarkers Market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Neurological Biomarkers Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 4. Global Neurological Biomarkers Market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 5. Global Neurological Biomarkers Market estimates & forecasts by End-use 2018-2027 (USD Billion)
TABLE 6. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Neurological Biomarkers Market
TABLE 56. List of primary sources, used in the study of global Neurological Biomarkers Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Neurological Biomarkers Market , report scope
TABLE 2. Global Neurological Biomarkers Market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Neurological Biomarkers Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 4. Global Neurological Biomarkers Market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 5. Global Neurological Biomarkers Market estimates & forecasts by End-use 2018-2027 (USD Billion)
TABLE 6. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Neurological Biomarkers Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Neurological Biomarkers Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Neurological Biomarkers Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Neurological Biomarkers Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Neurological Biomarkers Market
TABLE 56. List of primary sources, used in the study of global Neurological Biomarkers Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Neurological Biomarkers Market , research methodology
FIG 2. Global Neurological Biomarkers Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neurological Biomarkers Market , key trends 2020
FIG 5. Global Neurological Biomarkers Market , growth prospects 2021-2027
FIG 6. Global Neurological Biomarkers Market , porters 5 force model
FIG 7. Global Neurological Biomarkers Market , pest analysis
FIG 8. Global Neurological Biomarkers Market , value chain analysis
FIG 9. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Neurological Biomarkers Market , regional snapshot 2018 & 2027
FIG 15. North America Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 16. Europe Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 18. Latin America Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 19. Global Neurological Biomarkers Market , company market share analysis (2020)
FIG 1. Global Neurological Biomarkers Market , research methodology
FIG 2. Global Neurological Biomarkers Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neurological Biomarkers Market , key trends 2020
FIG 5. Global Neurological Biomarkers Market , growth prospects 2021-2027
FIG 6. Global Neurological Biomarkers Market , porters 5 force model
FIG 7. Global Neurological Biomarkers Market , pest analysis
FIG 8. Global Neurological Biomarkers Market , value chain analysis
FIG 9. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Neurological Biomarkers Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Neurological Biomarkers Market , regional snapshot 2018 & 2027
FIG 15. North America Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 16. Europe Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 18. Latin America Neurological Biomarkers Market 2018 & 2027 (USD Billion)
FIG 19. Global Neurological Biomarkers Market , company market share analysis (2020)
